Acute and long-term effects of acetazolamide in presumed high loop gain sleep apnea

The acute effect during positive pressure titration and long term efficacy of acetazolamide (AZT) in high loop gain sleep apnea (HLGSA) is inadequately assessed. We predicted that AZT may improve HLGSA in both conditions. A retrospective analysis of polysomnograms from patients with presumed HLGSA a...

Full description

Saved in:
Bibliographic Details
Published in:Sleep medicine 2023-07, Vol.107, p.137-148
Main Authors: Ni, Yue-Nan, Holzer, Rena C., Thomas, Robert Joseph
Format: Article
Language:English
Subjects:
Acetazolamide
Acetazolamide - pharmacology
Acetazolamide - therapeutic use
Aged
Apnea hypopnea index
Continuous Positive Airway Pressure
Female
Humans
Male
Middle Aged
Positive airway pressure
Respiration
Retrospective Studies
Sleep Apnea Syndromes - drug therapy
Sleep Apnea, Obstructive - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The acute effect during positive pressure titration and long term efficacy of acetazolamide (AZT) in high loop gain sleep apnea (HLGSA) is inadequately assessed. We predicted that AZT may improve HLGSA in both conditions. A retrospective analysis of polysomnograms from patients with presumed HLGSA and residual respiratory instability administered AZT (125 or 250 mg) about 3 h into an initially drug-free positive pressure titration. A responder was defined as ≥ 50% reduction of the apnea hypopnea index(AHI 3% or arousal) before and after AZT. A multivariable logistic regression model estimated responder predictors. Long term efficacy of AZT was assessed by comparing both auto-machine (aREIFLOW) and manually scored respiratory events (sREIFLOW) extracted from the ventilator, prior to and after 3 months of AZT, in a subset. Of the 231 participants (median age of 61[51–68] years) and 184 (80%) males in the acute effect testing: 77 and 154 patients were given 125 mg and 250 mg AZT. Compared to PAP alone, PAP plus AZT was associated with a lower breathing related arousal index (8 [3-16] vs. 5 [2-10], p 
ISSN:1389-9457
1878-5506
DOI:10.1016/j.sleep.2023.04.010